Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Skystar Bio-Pharmaceutical Co (NASDAQ:SKBI)

1.17
Delayed Data
As of Aug 28
 -0.03 / -2.50%
Today’s Change
1.03
Today|||52-Week Range
5.92
-72.27%
Year-to-Date
No recent news for Skystar Bio-Pharmaceutical Co.

Today’s Trading

Previous close1.20
Today’s open1.20
Day’s range1.12 - 1.20
Volume9,316
Average volume (3 months)18,374
Market cap$10.2M
Dividend yield--
Data as of 3:41pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+66.27%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.14%
Revenue growth (last year)+26.49%
P/E ratio0.8
Price/Sales0.64
Price/Book0.08

Competitors

 Today’s
change
Today’s
% change
BSPMBiostar Pharmaceutic...-0.01-1.33%
RCPIRock Creek Pharmaceu...+0.06+6.38%
CPHIChina Pharma Holding...+0.01+3.69%
KBIOKaloBios Pharmaceuti...+0.04+2.03%
Data as of 3:59pm ET, 08/28/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$42.5M
Annual profit (last year)$10.5M
Net profit margin24.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Wei Bing Lu
CFO &
Principal Accounting Officer
Bing Mei
Corporate headquarters
Xi'an, Shaanxi

Forecasts

Partner Offers